New real-world data from the 1INSPIRE study shows that frontline niraparib (Zejula) maintenance is well-tolerated in patients ...

Radon already has a well-earned reputation as a lung cancer threat. Now a systematic review published in Frontiers in Public ...

A woman recalled the heartbreak and emotions felt when she learned she had ovarian cancer in her 30s, nearly three decades ...

Mirvetuximab soravtansine shows 16.4-month OS in ovarian cancer, though poor ECOG status and toxicity significantly impact ...

The advent of mRNA vaccines against SARS-CoV-2 in 2020 changed the course of the COVID-19 pandemic. Now, the Nobel ...

The clinical presentation of gastrointestinal stromal tumours (GISTs) can vary and can be attributed to tumour mass effect or gastrointestinal haemorrhage. We present the rare case of a female in her ...

Volastra Therapeutics, a clinical-stage oncology company pioneering therapies targeting chromosomal instability (CIN), today ...

Postmenopausal women living in a high radon zone have significantly higher risks for ovarian cancer incidence and mortality, ...

A new study suggests that a single blood sample could soon detect multiple cancers, including liver, stomach, and lung cancer ...

Penn Medicine researchers will present advances in CAR T cell therapy, cancer interception, prevention, and more at the 2026 AACR Annual Meeting.

Ovarian cancer is the most lethal malignancy of the female reproductive system. Due to its insidious early symptoms and the ...

Sofetabart mipitecan (LY4170156), an investigational folate receptor alpha (FRα)-targeted antibody-drug conjugate (ADC), elicited strong antitumor activity in patients with recurrent ...